Literature DB >> 25264167

Congenital myasthenic syndrome in Japan: ethnically unique mutations in muscle nicotinic acetylcholine receptor subunits.

Yoshiteru Azuma1, Tomohiko Nakata1, Motoki Tanaka2, Xin-Ming Shen3, Mikako Ito4, Satoshi Iwata4, Tatsuya Okuno4, Yoshiko Nomura5, Naoki Ando6, Keiko Ishigaki7, Bisei Ohkawara4, Akio Masuda4, Jun Natsume8, Seiji Kojima8, Masahiro Sokabe2, Kinji Ohno9.   

Abstract

Congenital myasthenic syndromes (CMS) are caused by mutations in genes expressed at the neuromuscular junction. Most CMS patients have been reported in Western and Middle Eastern countries, and only four patients with COLQ mutations have been reported in Japan. We here report six mutations in acetylcholine receptor (AChR) subunit genes in five Japanese patients. Five mutations are novel, and one mutation is shared with a European American patient but with a different haplotype. Among the observed mutations, p.Thr284Pro (p.Thr264Pro according to the legacy annotation) in the epsilon subunit causes a slow-channel CMS. Five other mutations in the delta and epsilon subunits are splice site, frameshift, null, or missense mutations causing endplate AChR deficiency. We also found a heteroallelic p.Met465Thr in the beta subunit in another patient. p.Met465Thr, however, was likely to be polymorphism, because single channel recordings showed mild shortening of channel openings without affecting cell surface expression of AChR, and the minor allelic frequency of p.Met465Thr was 5.1% in the Japanese population. Lack of shared mutant alleles between the Japanese and the other patients suggests that most mutations described here are ethnically unique or de novo in each family.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylcholine receptor; Congenital myasthenic syndromes; Endplate acetylcholine receptor deficiency; Fast channel syndrome; Slow channel syndrome

Mesh:

Substances:

Year:  2014        PMID: 25264167     DOI: 10.1016/j.nmd.2014.09.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

1.  Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.

Authors:  Hacer Durmus; Xin-Ming Shen; Piraye Serdaroglu-Oflazer; Bulent Kara; Yesim Parman-Gulsen; Coskun Ozdemir; Joan Brengman; Feza Deymeer; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2017-11-28       Impact factor: 4.296

2.  Mutations Causing Slow-Channel Myasthenia Reveal That a Valine Ring in the Channel Pore of Muscle AChR is Optimized for Stabilizing Channel Gating.

Authors:  Xin-Ming Shen; Tatsuya Okuno; Margherita Milone; Kenji Otsuka; Koji Takahashi; Hirofumi Komaki; Elizabeth Giles; Kinji Ohno; Andrew G Engel
Journal:  Hum Mutat       Date:  2016-08-21       Impact factor: 4.878

3.  Mitochondrial disorder mimicking rheumatoid disease.

Authors:  Josef Finsterer; Madleine Melichart-Kotig; Adelheid Woehrer
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

4.  Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia.

Authors:  Li Di; Hai Chen; Yan Lu; Duygu Selcen; Andrew G Engel; Yuwei Da; Xin-Ming Shen
Journal:  Neurology       Date:  2020-09-09       Impact factor: 9.910

5.  A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family.

Authors:  Jia-Ze Tan; Yuan Man; Fei Xiao
Journal:  Chin Med J (Engl)       Date:  2016-11-05       Impact factor: 2.628

6.  Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome.

Authors:  Rachel Thompson; Gisèle Bonne; Paolo Missier; Hanns Lochmüller
Journal:  Emerg Top Life Sci       Date:  2019-01-28

7.  No Hot Spot Mutations CHRNE c.1327 delG, CHAT c.914T>C, and RAPSN c.264C>A in Iranian Patients with Congenital Myasthenic Syndrome.

Authors:  Sima Parvizi Omran; Massod Houshmand; Donkor Dominic; Zahra Farjami; Parvaneh Karimzadeh
Journal:  Iran J Child Neurol       Date:  2019
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.